CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 157 enrolled
Drug / intervention
MRI-TRUS fusion prostate biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03615131
NCT03615131N/ACompleted
CompareCT.gov

Accuracy of Multi-parametric Prostate MRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in the Detection of Prostate Cancer:

Kantonsspital Winterthur KSW·observational·Posted Aug 3, 2018·Updated Aug 22, 2018

In Brief

An observational study evaluating MRI-TRUS fusion prostate biopsy for Prostate Cancer. Completed, enrolled 157 participants across 1 site.

Detailed Summary

The investigators examined whether a high PI-RADS v2 score correlates with the presence of prostate cancer. In addition, the investigator inspected whether the lesion size as determined by mpMRI correlates with the presence of prostate cancer. Furthermore, the investigators study aimed to determine the sensitivity and specificity of mpMRI with respect to prostate carcinoma detection.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 3, 2018
Enrollment StartSep 1, 2015
Primary CompletionMar 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.9 years ago

Interventions

MRI-TRUS fusion prostate biopsyother

First an advanced MRI prostate image is obtained, annotated and recorded by the Radiology of the Kantonsspital Winterthur. Next, using special fusion technology, the recorded MRI image is fused with a live transrectal ultrasound by the Urologist who performs a MRI/TRUS fusion biopsy.